Released on = March 20, 2006, 2:57 pm

Press Release Author = Richard Lanzara, Ph.D.

Industry = Biotech

Press Release Summary = Bio Balance has developed new and exciting technologies to
prevent drug desensitization, a side effect of many drugs. This will lead to the
development of safer drugs with better therapeutic profiles.

Press Release Body = Bio Balance is a biotechnology and pharmaceutical drug
discovery company that uses biophysical descriptions at the interface of
mathematics, physics, chemistry and biology to understand the molecular basis for
receptor activation. Bio Balance\'s website (see http://www.bio-balance.com) provides
cutting-edge descriptions of the science behind how our receptors and senses work.
This unique site offers many free resources to understand the science behind the
work.

The philosophy behind Bio Balance is that accurate descriptions of drug-receptor
interactions will lead to the development of better and safer pharmaceuticals. By
using this approach, Bio Balance has developed new and exciting technologies to
prevent drug desensitization, a side effect of many drugs. This will lead to the
development of safer drugs with better therapeutic profiles (see
http://www.bio-balance.com/DrugAB.html).

Our current receptor model applies molecular and mathematical models to understand
how our cellular receptors recognize a signal. This work spans almost two decades
and is now freely available on our website.



Web Site = http://www.bio-balance.com

Contact Details = Richard Lanzara, Ph.D.
President and Principle Scientific Officer
Bio Balance, Inc.
30 West 86th Street
New York, NY 10024
T: (212) 769-3877
F: (212) 769-3877
Email: rlanzara@bio-balance.com